COX-2 involvement in breast cancer metastasis to bone

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Oncogene

• Publication date

  2007-05-31

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/sj.onc.1210154PMID 17213821
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• COX-2 induces IL-11 production in human breast cancer cells.

  2006cited by this paper
• Involvement of IL-8 in COX-2-mediated bone metastases from breast cancer.

  2006cited by this paper
• Stimulation of cyclooxygenase-2 expression by bone-derived transforming growth factor-beta enhances bone metastases in breast cancer.

  2006cited by this paper
• Cyclooxygenase-2 Inhibitor Enhances the Efficacy of a Breast Cancer Vaccine: Role of IDO1

  2006cited by this paper
• Cyclooxygenase inhibitors modulate NK activities that control metastatic disease

  2005cited by this paper
• HER2/neu-induced mammary tumorigenesis and angiogenesis are reduced in cyclooxygenase-2 knockout mice.

  2005cited by this paper
• COX-2 overexpression increases motility and invasion of breast cancer cells.

  2005cited by this paper
• Histologically normal human mammary epithelia with silenced p16(INK4a) overexpress COX-2, promoting a premalignant program.

  2004cited by this paper
• Role of prostaglandin E2-dependent angiogenic switch in cyclooxygenase 2-induced breast cancer progression.

  2004cited by this paper
• Vitamin E Analog α-TEA and Celecoxib Alone and Together Reduce Human MDA-MB-435-FL-GFP Breast Cancer Burden and Metastasis in Nude Mice

  2004cited by this paper
• Cyclooxygenase-2 inhibitor induces apoptosis in breast cancer cells in an in vivo model of spontaneous metastatic breast cancer.

  2004cited by this paper
• Cyclooxygenase-2: a potential target in breast cancer.

  2004cited by this paper
• Antimetastatic activity of a cyclooxygenase-2 inhibitor

  2004cited by this paper
• Cox-2 overexpression increases motility and invasion of breast cancer cells

  2004cited by this paper
• A Simple Quantitative Method for Evaluation of Angiogenesis Activity

  2004cited by this paper
• MDA-MB-435 human breast carcinoma metastasis to bone

  2004cited by this paper
• Breast cancer cells induce osteoclast formation by stimulating host IL‐11 production and downregulating granulocyte/macrophage colony‐stimulating factor

  2004cited by this paper
• COX-2 Inhibitors for the Prevention of Breast Cancer

  2004cited by this paper
• Prostaglandin E2 induced the differentiation of osteoclasts in mouse osteoblast-depleted bone marrow cells.

  2003cited by this paper
• Interleukin-8 stimulation of osteoclastogenesis and bone resorption is a mechanism for the increased osteolysis of metastatic bone disease.

  2003cited by this paper
• A multigenic program mediating breast cancer metastasis to bone.

  2003cited by this paper
• Celecoxib, a selective cyclooxygenase 2 inhibitor, protects against human epidermal growth factor receptor 2 (HER-2)/neu-induced breast cancer.

  2002cited by this paper
• Cyclo-oxygenase inhibition reduces tumour growth and metastasis in an orthotopic model of breast cancer

  2002cited by this paper
• Prognostic significance of elevated cyclooxygenase-2 expression in breast cancer.

  2002cited by this paper
• Chemoprevention of gastrointestinal malignancies with nonsteroidal antiinflammatory drugs

  2002cited by this paper
• Effects of prostaglandin E2 on gene expression in primary osteoblastic cells from prostaglandin receptor knockout mice.

  2002cited by this paper
• Cyclooxygenase-2 Is Overexpressed in HER-2/neu-positive Breast Cancer

  2002cited by this paper
• Role of cyclooxygenase-2 in breast cancer.

  2002cited by this paper
• Involvement of Cyclo‐Oxygenase‐2 in Osteoclast Formation and Bone Destruction in Bone Metastasis of Mammary Carcinoma Cell Lines

  2002cited by this paper
• Breast cancer and NSAID use: a meta-analysis

  2001cited by this paper
• Suppression of intestinal polyps in Msh2-deficient and non-Msh2-deficient multiple intestinal neoplasia mice by a specific cyclooxygenase-2 inhibitor and by a dual cyclooxygenase-1/2 inhibitor.

  2001cited by this paper
• Overexpression of Cyclooxygenase-2 Is Sufficient to Induce Tumorigenesis in Transgenic Mice*

  2001cited by this paper
• Increased cyclooxygenase‐2 (cox‐2) expression and activity in a murine model of metastatic breast cancer

  2001cited by this paper
• COX‐2 is expressed in human pulmonary, colonic, and mammary tumors

  2000cited by this paper
• Chemoprevention of breast cancer in rats by celecoxib, a cyclooxygenase 2 inhibitor.

  2000cited by this paper
• The association between a mutated ras gene and cyclooxygenase-2 expression in human breast cancer cell lines.

  1999cited by this paper
• Role of Val509 in Time-dependent Inhibition of Human Prostaglandin H Synthase-2 Cyclooxygenase Activity by Isoform-selective Agents*

  1996cited by this paper
• Interleukin-11: a new cytokine critical for osteoclast development.

  1994cited by this paper
• A murine model of experimental metastasis to bone and bone marrow.

  1988cited by this paper

• Healing dynamics and surgery in breast cancer: rethinking a timeless challenge in light of advancing therapies and technologies

  2026cites this paper
• Breaking Immune Evasion in Breast Cancer by Targeting COX-2/PGE2 Pathway.

  2025cites this paper
• CtBP: A mediator of a metabolic switch from homeostasis to carcinogenesis

  2025cites this paper
• Synthesis, X-ray Crystallography, and Computational Analysis of 2,4-disubstituted-6,7-dihydro-5H-cyclopenta[4,5]thieno[2,3-d]pyrimidines as COX-2 Inhibitors and Anticancer Agents

  2025cites this paper
• Single crystal XRD analysis, Molecular docking, DFT studies, Hirshfeld analysis, antioxidant and anticancer activities of three natural carboxylic acids identified in Carica papaya leaves

  2024cites this paper
• Garlic peel extract as an antioxidant inhibits triple‐negative breast tumor growth and angiogenesis by inhibiting cyclooxygenase‐2 expression

  2024influential citation
• Molecular and Pathobiology of Canine Mammary Tumour: Defining a Translational Model for Human Breast Cancer.

  2024cites this paper
• Low-grade Chronic Inflammation: A Shared Mechanism for Chronic Diseases.

  2024cites this paper
• Metabolic crosstalk between stromal and malignant cells in the bone marrow niche

  2023cites this paper
• Selective COX-2 Inhibitor Etoricoxib’s Liposomal Formulation Attenuates M2 Polarization of TAMs and Enhances its Anti-metastatic Potential

  2023cites this paper
• Switching of newly synthesized linker-based derivatives of non-steroidal anti-inflammatory drugs toward anti-inflammatory and anticancer activity.

  2023cites this paper
• Sensitization of Resistant Cells with a BET Bromodomain Inhibitor in a Cell Culture Model of Deep Intrinsic Resistance in Breast Cancer

  2023cites this paper
• Technetium-99m labeled core shell hyaluronate nanoparticles as tumor responsive, metastatic skeletal lesion targeted combinatorial theranostics.

  2023cites this paper
• Identification of Immune and Hypoxia Risk Classifier to Estimate Immune Microenvironment and Prognosis in Cervical Cancer

  2022cites this paper
• Antioxidant and cytotoxic activities of selected salicylidene imines: experimental and computational study

  2022cites this paper
• Expression Profiling of Selected Immune Genes and Trabecular Microarchitecture in Breast Cancer Skeletal Metastases Model: Effect of α–Tocopherol Acetate Supplementation

  2022cites this paper
• Implementing subtype‐specific pre‐clinical models of breast cancer to study pre‐treatment aspirin effects

  2022cites this paper
• Sensitization of Resistant Breast Cancer Cells with a Jumonji Family Histone Demethylase Inhibitor

  2022cites this paper
• Natural-derived COX-2 inhibitors as Anticancer Drugs: A Review of Their Structure Diversity and Mechanism of Action.

  2022cites this paper
• Modulatory Effects of Estradiol and Its Mixtures with Ligands of GPER and PPAR on MAPK and PI3K/Akt Signaling Pathways and Tumorigenic Factors in Mouse Testis Explants and Mouse Tumor Leydig Cells

  2022cites this paper
• Inhibition of resistant triple-negative breast cancer cells with low-dose 6-mercaptopurine and 5-azacitidine

  2021cites this paper
• Integrative Bioinformatics Study of Tangeretin Potential Targets for Preventing Metastatic Breast Cancer

  2021cites this paper
• The Role of Inflammation in Breast and Prostate Cancer Metastasis to Bone

  2021cites this paper
• EP4 as a Therapeutic Target to Impede Breast Cancer-associated Angiogenesis and Lymphangiogenesis

  2021cites this paper
• Effects of Analgesics on Tumor Growth in Mouse Models of Prostate Cancer Bone Metastasis.

  2021cites this paper
• Chemopreventive and Anticancer Property of Selenoproteins in Obese Breast Cancer

  2021cites this paper
• Bioactive lipids and cancer metastasis to bone

  2021cites this paper
• Reducing PMA-induced COX-2 expression using a herbal formulation in MCF-7 breast cancer cells

  2021cites this paper
• Iminodibenzyl induced redirected COX-2 activity inhibits breast cancer progression

  2021cites this paper
• Extracellular ATP Mediates Cancer Cell Migration and Invasion Through Increased Expression of Cyclooxygenase 2

  2021cites this paper
• Iminodibenzyl induced redirected COX-2 activity inhibits breast cancer progression

  2021cites this paper
• The Adipokine Component in the Molecular Regulation of Cancer Cell Survival, Proliferation and Metastasis

  2021cites this paper
• Prostaglandin E2 Receptor 4 (EP4) as a Therapeutic Target to Impede Breast Cancer-Associated Angiogenesis and Lymphangiogenesis

  2021cites this paper
• Cyclooxygenase-2 mediates gefitinib resistance in non-small cell lung cancer through the EGFR/PI3K/AKT axis

  2020cites this paper
• Phycocyanin C a Natural Product with Impressive Therapeutic Efficacy for Inhibition of Breast Tumors’ Growth and Metastasis in Vivo

  2020cites this paper
• Spirulina extract enriched for Braun‐type lipoprotein (Immulina®) for inhibition of 4T1 breast tumors' growth and metastasis

  2020cites this paper
• Integrative Bioinformatics Study Reveals Tangeretin Targets and Molecular Mechanisms Against Metastatic Breast Cancer

  2020cites this paper
• The Role of Adipokines and Bone Marrow Adipocytes in Breast Cancer Bone Metastasis

  2020cites this paper
• Tumor Dormancy in The Bone

  2019cites this paper
• Annexin A1 peptide and endothelial cell‐conditioned medium modulate cervical tumorigenesis

  2019cites this paper
• Aspirin blocks formation of metastatic intravascular niches by inhibiting platelet-derived COX-1/thromboxane A2

  2019cites this paper
• Roles of omental and bone marrow adipocytes in tumor biology

  2019cites this paper
• S-nitrosylation and its role in breast cancer angiogenesis and metastasis.

  2019cites this paper
• Evaluation of 6-mercaptopurine in a cell culture model of adaptable triple-negative breast cancer with metastatic potential

  2019cites this paper
• C-phycocyanin: a natural product with radiosensitizing property for enhancement of colon cancer radiation therapy efficacy through inhibition of COX-2 expression

  2019cites this paper
• Tumor Hypoxia As an Enhancer of Inflammation-Mediated Metastasis: Emerging Therapeutic Strategies

  2018cites this paper
• Mechanistic evidence that benzo[a]pyrene promotes an inflammatory microenvironment that drives the metastatic potential of human mammary cells

  2018cites this paper
• Breast cancer bone metastases: pathogenesis and therapeutic targets.

  2018cites this paper
• Molecular Mechanisms and Emerging Therapeutic Targets of Triple-Negative Breast Cancer Metastasis

  2018cites this paper
• Synthesis, in vitro and in silico evaluation of novel trans-stilbene analogues as potential COX-2 inhibitors.

  2018cites this paper
• Cancer Metastases to Bone: Concepts, Mechanisms, and Interactions with Bone Osteoblasts

  2018influential citation
• CXCR2 promotes breast cancer metastasis and chemoresistance via suppression of AKT1 and activation of COX2.

  2018cites this paper
• 15-Deoxy-Δ12,14-prostaglandin J2 activates PI3K-Akt signaling in human breast cancer cells through covalent modification of the tumor suppressor PTEN at cysteine 136.

  2018cites this paper
• Role of Drug Anesthesia and Cancer

  2017influential citation
• Lipid Osteoclastokines Regulate Breast Cancer Bone Metastasis

  2017cites this paper
• Osteoclasts: Essentials and Methods

  2017cites this paper
• Chapter Three: Selenoproteins and Metastasis

  2017cites this paper
• Obesity and breast cancer - Role of estrogens and the molecular underpinnings of aromatase regulation in breast adipose tissue.

  2017cites this paper
• Induction of Continuous Expression of Cyclooxygenase -2 in Human Breast Cancer Cell Line Using COX-2 cDNA Plasmid Transfection

  2017cites this paper
• DEPARTMENT OF WOMEN’S AND CHILDRENS HEALTH Karolinska Institutet, Stockholm, Sweden NOVEL THERAPY FOR NEUROBLASTOMA; FOCUS ON PROSTAGLANDIN E2 AND MICROSOMAL PROSTAGLANDIN E SYNTHASE-1

  2017cites this paper
• WIN 55,212-2 Inhibits the Epithelial Mesenchymal Transition of Gastric Cancer Cells via COX-2 Signals

  2016cites this paper
• Cannabidiolic acid-mediated selective down-regulation of c-fos in highly aggressive breast cancer MDA-MB-231 cells: possible involvement of its down-regulation in the abrogation of aggressiveness

  2016cites this paper
• Rhus coriaria suppresses angiogenesis, metastasis and tumor growth of breast cancer through inhibition of STAT3, NFκB and nitric oxide pathways

  2016cites this paper
• Impact of cyclooxygenase-2 over-expression on the prognosis of breast cancer patients.

  2016cites this paper
• Flavokawain B induced cytotoxicity in two breast cancer cell lines, MCF-7 and MDA-MB231 and inhibited the metastatic potential of MDA-MB231 via the regulation of several tyrosine kinases In vitro

  2016cites this paper
• Important Role of FTO in the Survival of Rare Panresistant Triple-Negative Inflammatory Breast Cancer Cells Facing a Severe Metabolic Challenge

  2016cites this paper
• Docosahexaenoic acid suppresses breast cancer cell metastasis by targeting matrix-metalloproteinases

  2016cites this paper
• COX-2 inhibitors: a novel strategy in the management of breast cancer.

  2016cites this paper
• Do postoperative NSAIDs improve breast cancer outcomes? A Best Evidence Topic.

  2016cites this paper
• Caffeic acid, a phyto polyphenol mitigates fluoride induced hepatotoxicity in rats: A possible mechanism.

  2015cites this paper
• Dormancy and growth of metastatic breast cancer cells in a bone-like microenvironment

  2015cites this paper
• Mechanistic Role of MicroRNA in Cancer Chemoprevention by Nonsteroidal Anti-inflammatory Drugs

  2015cites this paper
• Molecular alterations that drive breast cancer metastasis to bone.

  2015cites this paper
• In vivo antitumor and antimetastatic effects of flavokawain B in 4T1 breast cancer cell-challenged mice

  2015cites this paper
• Targeting the COX-2 Pathway to Improve Therapeutic Response in the Obese Breast Cancer Patient Population

  2015cites this paper
• Protein deregulation associated with breast cancer metastasis.

  2015cites this paper
• Can Exosomes Induced by Breast Involution Be Markers for the Poor Prognosis and Prevention of Postpartum Breast Cancer

  2015cites this paper
• Isoliquiritigenin Inhibits Metastatic Breast Cancer Cell-induced Receptor Activator of Nuclear Factor Kappa-B Ligand/Osteoprotegerin Ratio in Human Osteoblastic Cells

  2015cites this paper
• Pro-migratory actions of the prostacyclin receptor in human breast cancer cells that over-express cyclooxygenase-2.

  2015cites this paper
• in vivo antitumor and antimetastatic effects of flavokawain B in 4T1 breast cancer cell-challenged mice

  2015cites this paper
• Molecular profiling of 6,892 colorectal cancer samples suggests different possible treatment options specific to metastatic sites

  2015cites this paper
• DNA microarray analysis of genes in highly metastatic 4T1E/M3 murine breast cancer cells following exposure to cannabidiolic acid

  2015cites this paper
• CYCLOOXYGENASE-2 169C>G GENE POLYMORPHISM AND PROSTAGLANDIN E2 LEVEL IN BREAST CANCER

  2015cites this paper
• Punica granatum and its therapeutic implications on breast carcinogenesis: A review

  2015cites this paper
• Altering the Microenvironment to Promote Dormancy of Metastatic Breast Cancer Cell in a 3D Bone Culture System

  2015cites this paper
• Breast cancer subtypes predispose the site of distant metastases.

  2015cites this paper
• Inhibitory effect of ethanol extract of Ocimum sanctum on osteopontin mediated metastasis of NCI-H460 non-small cell lung cancer cells

  2014influential citation
• Metastasis-suppressor transcript destabilization through TARBP2 binding of mRNA hairpins

  2014cites this paper
• Highly Adaptable Triple-Negative Breast Cancer Cells as a Functional Model for Testing Anticancer Agents

  2014cites this paper
• NDRG2 Controls COX-2/PGE2-Mediated Breast Cancer Cell Migration and Invasion

  2014cites this paper
• Post-diagnostic prescriptions for low-dose aspirin and breast cancer-specific survival: a nested case-control study in a breast cancer cohort from the UK Clinical Practice Research Datalink

  2014cites this paper
• COX-2 drives metastatic breast cells from brain lesions into the cerebrospinal fluid and systemic circulation.

  2014cites this paper
• Priority Report COX-2 DrivesMetastatic Breast Cells fromBrain Lesions into the Cerebrospinal Fluid and Systemic Circulation

  2014cites this paper
• Global Gene Expression Analysis of Canine Osteosarcoma Stem Cells Reveals a Novel Role for COX-2 in Tumour Initiation

  2014cites this paper
• COX2 expression in neuroblastoma increases tumorigenicity but does not affect cell death in response to the COX2 inhibitor celecoxib

  2014cites this paper
• Bone marrow fat: linking adipocyte-induced inflammation with skeletal metastases

  2014cites this paper
• Down-regulation of cyclooxygenase-2 (COX-2) by cannabidiolic acid in human breast cancer cells.

  2014cites this paper
• Molecular Mechanisms of Bone Metastasis and Associated Muscle Weakness

  2014cites this paper
• 9. SPONSORING / MONITORING AGENCY NAME(S) AND ADDRESS(ES)

  2014cites this paper
• Polyunsaturated fatty acids, genetic susceptibility, and breast cancer incidence and survival

  2014cites this paper